Full Text Available
Note: Clicking the button above will open the full text document at the original institutional repository in a new window.
Use of JYNNEOS (Smallpox and Mpox Vaccine, Live, Nonreplicating) for Persons Aged ≥18 Years at Risk for Mpox During an Mpox Outbreak: Recommendations of the Advisory Committee on Immunization Practices - United States, 2023
Saved in:
| Published in: | MMWR Morbidity and Mortality Weekly Report |
|---|---|
| Format: | Online Article RSS Article |
| Published: |
2025
|
| Subjects: | |
| Tags: |
No Tags, Be the first to tag this record!
|
Similar Items: Use of JYNNEOS (Smallpox and Mpox Vaccine, Live, Nonreplicating) for Persons Aged ≥18 Years at Risk for Mpox During an Mpox Outbreak: Recommendations of the Advisory Committee on Immunization Practices - United States, 2023
- Clade Ib Mpox Outbreak - Kenya, July 2024-February 2025
- Orthopoxvirus Antibodies in Feral Mammals in Mpox Outbreak Areas, Nigeria, 2021–2022
- Mpox in South Asia: A Narrative Review on Epidemiology, Preparedness, and Preventive Strategies
- Decoding Vaccine Hesitancy in Mpox Across Multiple Middle Eastern Countries: Public Knowledge, Attitudes, Worry, Conspiracy Beliefs, and Acceptance
- Mpox seroprevalence in general population groups in South-Kivu, Democratic Republic of the Congo: a comparative description before and during the clade Ib outbreak
- Clade II Mpox Infections Among Cruise Ship Passengers and Crew Members - United States, 2024